C. Lambek

发表

INACCURACY OF ESTIMATIONS OF S PHASE FRACTION BY REDUCTION IN CLONING EFFICIENCY WITH HYDROXYUREA OR TRITIATED THYMIDINE

B. Clarkson, A. Yen, C. Lambek, 1981, Cell and tissue kinetics.

Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib.

S. Larson, M. Namavari, D. Veach, 2007, Journal of medicinal chemistry.

New understanding of the pathogenesis of CML: a prototype of early neoplasia

A. Strife, C. Lambek, N. Carpino, 1997, Leukemia.

Growth characteristics of leukemic and normal hematopoietic cells in Ph' + chronic myelogenous leukemia and effects of intensive treatment.

J. Burchenal, S. Jhanwar, R. Chaganti, 1982, Blood.

Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells.

J. Gabrilove, K. Welte, B. Clarkson, 1987, Blood.

Discordant maturation as the primary biological defect in chronic myelogenous leukemia.

B. Clarkson, A. Strife, C. Lambek, 1988, Cancer research.

Constitutive expression of p53 protein in enriched normal human marrow blast cell populations.

Z. Darżynkiewicz, S. Bruno, B. Clarkson, 1992, Blood.

A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations.

B. Clarkson, D. Wojciechowicz, A. Strife, 1994, Leukemia.

Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.

J. Kuriyan, J. Bertino, W. Bornmann, 2002, Cancer research.

Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210(BCR-ABL).

S. Jhanwar, B. Clarkson, A. Strife, 2000, Leukemia research.

Proliferative potential of subpopulations of granulocyte-macrophage progenitor cells in normal subjects and chronic myelogenous leukemia patients

H. Thaler, B. Clarkson, A. Strife, 1983 .

Proliferative potential of subpopulations of granulocyte-macrophage progenitor cells in normal subjects and chronic myelogenous leukemia patients.

H. Thaler, B. Clarkson, A. Strife, 1983, Blood.

marrow blast cell populations (see comments) Constitutive expression of p53 protein in enriched normal human

Z. Darżynkiewicz, S. Bruno, B. Clarkson, 2012 .

Mechanism for Control of Synthesis of Semliki Forest Virus 26S and 42S RNA

D. Sawicki, L. Kááriáinen, C. Lambek, 1978, Journal of virology.

Integration of molecular and biological abnormalities in quest for selective treatment of chronic myelogenous leukemia (CML).

A. Strife, A. Perez, C. Lambek, 1993, Leukemia & lymphoma.

Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies

A. Strife, C. Lambek, C. Liu, 2003, Leukemia.

Anomalistic Signaling as a Possible Biochemical Explanation for Discordant Maturation in Chronic Myelogenous Leukemia (CML)

A. Strife, C. Lambek, N. Carpino, 1998 .

Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.

B. Clarkson, A. Strife, A. Perez, 1991, Leukemia.

Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells.

Z. Darżynkiewicz, B. Clarkson, R. Silver, 2003, Molecular cancer research : MCR.

Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities

T. G. Marr, A. Olshen, A. Viale, 2011, Journal of oncology.

Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand.

Z. Darżynkiewicz, S. Bruno, B. Clarkson, 1993, Leukemia research.

Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.

Z. Darżynkiewicz, S. Bruno, B. Clarkson, 1993, Cancer research.

Enrichment of hematopoietic progenitor cells (CFUC and BFUE) from human peripheral blood.

B. Clarkson, A. Strife, C. Lambek, 1982, Experimental hematology.

Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210BCR-ABL

S. Jhanwar, B. Clarkson, A. Strife, 2000 .

The effects of transforming growth factor β3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood

Z. Darżynkiewicz, P. Dijke, B. Clarkson, 1991 .

c-Kit Receptor Tyrosine Kinases Characterization of Potent Inhibitors of the Bcr-Abl and the Updated

J. Kuriyan, J. Bertino, W. Bornmann, 2002 .